Application 216986
- Type
- NDA
- Sponsor
- GUERBET
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 1.4553GM/3ML (485.1MG/ML) | Yes | Yes |
| 002 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 3.63825GM/7.5ML (485.1MG/ML) | Yes | Yes |
| 003 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 4.851GM/10ML (485.1MG/ML) | Yes | Yes |
| 004 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 7.2765GM/15ML (485.1MG/ML) | Yes | Yes |
| 005 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 14.553GM/30ML (485.1MG/ML) | Yes | Yes |
| 006 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 24.255GM/50ML (485.1MG/ML) | Yes | Yes |
| 007 | ELUCIREM | GADOPICLENOL | SOLUTION;INTRAVENOUS | 48.51GM/100ML (485.1MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216986-001 | ELUCIREM | GADOPICLENOL | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | |
| N216986-002 | ELUCIREM | GADOPICLENOL | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | |
| N216986-003 | ELUCIREM | GADOPICLENOL | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | |
| N216986-004 | ELUCIREM | GADOPICLENOL | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | |
| N216986-005 | ELUCIREM | GADOPICLENOL | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | |
| N216986-006 | ELUCIREM | GADOPICLENOL | 24.255GM/50ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | |
| N216986-007 | ELUCIREM | GADOPICLENOL | 48.51GM/100ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N216986-001 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-001 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-001 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | |
| N216986-001 | 12064487 | 2040-01-17 | U-4424 | 2026-03-05 | |
| N216986-002 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-002 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-002 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | |
| N216986-002 | 12064487 | 2040-01-17 | U-4424 | 2026-03-05 | |
| N216986-003 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-003 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-003 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | |
| N216986-003 | 12064487 | 2040-01-17 | U-4424 | 2026-03-05 | |
| N216986-004 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-004 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-004 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | |
| N216986-004 | 12064487 | 2040-01-17 | U-4424 | 2026-03-05 | |
| N216986-005 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-005 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-005 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | |
| N216986-005 | 12064487 | 2040-01-17 | U-4424 | 2026-03-05 | |
| N216986-006 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-006 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-006 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | |
| N216986-006 | 12064487 | 2040-01-17 | U-4424 | 2026-03-05 | |
| N216986-007 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | |
| N216986-007 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | |
| N216986-007 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N216986-001 | NCE | 2027-09-21 |
| N216986-001 | NPP | 2029-02-20 |
| N216986-002 | NCE | 2027-09-21 |
| N216986-002 | NPP | 2029-02-20 |
| N216986-003 | NCE | 2027-09-21 |
| N216986-003 | NPP | 2029-02-20 |
| N216986-004 | NCE | 2027-09-21 |
| N216986-004 | NPP | 2029-02-20 |
| N216986-005 | NCE | 2027-09-21 |
| N216986-005 | NPP | 2029-02-20 |
| N216986-006 | NCE | 2027-09-21 |
| N216986-006 | NPP | 2029-02-20 |
| N216986-007 | NCE | 2027-09-21 |
| N216986-007 | NPP | 2029-02-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N216986-001 | ELUCIREM | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-002 | ELUCIREM | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-003 | ELUCIREM | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-004 | ELUCIREM | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-005 | ELUCIREM | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-006 | ELUCIREM | 24.255GM/50ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-007 | ELUCIREM | 48.51GM/100ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-001 | ELUCIREM | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-002 | ELUCIREM | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-003 | ELUCIREM | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-004 | ELUCIREM | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-005 | ELUCIREM | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-006 | ELUCIREM | 24.255GM/50ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-007 | ELUCIREM | 48.51GM/100ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-001 | ELUCIREM | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-002 | ELUCIREM | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-003 | ELUCIREM | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-004 | ELUCIREM | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-005 | ELUCIREM | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-006 | ELUCIREM | 24.255GM/50ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-007 | ELUCIREM | 48.51GM/100ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-001 | ELUCIREM | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-002 | ELUCIREM | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-003 | ELUCIREM | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-004 | ELUCIREM | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-005 | ELUCIREM | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-006 | ELUCIREM | 24.255GM/50ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-007 | ELUCIREM | 48.51GM/100ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-001 | ELUCIREM | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-002 | ELUCIREM | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-003 | ELUCIREM | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-004 | ELUCIREM | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-005 | ELUCIREM | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-006 | ELUCIREM | 24.255GM/50ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-007 | ELUCIREM | 48.51GM/100ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-001 | ELUCIREM | 1.4553GM/3ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-002 | ELUCIREM | 3.63825GM/7.5ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-003 | ELUCIREM | 4.851GM/10ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-004 | ELUCIREM | 7.2765GM/15ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-005 | ELUCIREM | 14.553GM/30ML (485.1MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2022-09-21 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N216986-001 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-001 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-001 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-002 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-002 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-002 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-003 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-003 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-003 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-004 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-004 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-004 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-005 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-005 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-005 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-006 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-006 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-006 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-007 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-007 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-007 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-001 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-001 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-001 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-002 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-002 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-002 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-003 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-003 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-003 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-004 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-004 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-004 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-005 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-005 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-005 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-006 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-006 | 10973934 | 2039-08-06 | Drug substance | 2022-11-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-006 | 11590246 | 2040-01-17 | Drug product | 2023-03-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-007 | 8114863 | 2028-09-19 | Drug substance | 2022-11-28 | 31067a03dcf5… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N216986-001 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-002 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-003 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-004 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-005 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-006 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216986-007 | NCE | 2027-09-21 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-001 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-002 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-003 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-004 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-005 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-006 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216986-007 | NCE | 2027-09-21 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-001 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-002 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-003 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-004 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-005 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-006 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216986-007 | NCE | 2027-09-21 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-001 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-002 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-003 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-004 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-005 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-006 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216986-007 | NCE | 2027-09-21 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-001 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-002 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-003 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-004 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-005 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-006 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216986-007 | NCE | 2027-09-21 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-001 | NCE | 2027-09-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-002 | NCE | 2027-09-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-003 | NCE | 2027-09-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-004 | NCE | 2027-09-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216986-005 | NCE | 2027-09-21 | 03ed91905a0d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vueway | GADOPICLENOL | BRACCO DIAGNOSTICS INC | 192725e9-e83e-1a36-33f2-abee55792ab3 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 216986 NDA216986 0270-7030 0270-7015 0270-7020 0270-7035 0270-7025 |
| ELUCIREM | GADOPICLENOL | Guerbet LLC | ca582f31-1042-487f-82e4-533f1b541902 | 2026-02-22 | Boxed warning, Warnings, Adverse reactions | 216986 NDA216986 67684-4233 67684-4231 67684-4232 67684-4241 67684-4230 67684-4250 67684-4242 67684-4240 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0270-7015 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7015 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7020 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7025 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7030 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 0270-7035 | Vueway | Gadopiclenol | BRACCO DIAGNOSTICS INC | NDA | Current |
| 67684-4230 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4230 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4230 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4231 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4231 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4231 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4232 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4232 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4232 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4233 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4240 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4241 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4242 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
| 67684-4250 | ELUCIREM | gadopiclenol | Guerbet LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85133 | SUPPL | 2026-02-24 |
| 85112 | SUPPL | 2026-02-24 |
| 85147 | SUPPL | 2026-02-20 |
| 81486 | SUPPL | 2025-03-07 |
| 81466 | SUPPL | 2025-03-06 |
| 79414 | SUPPL | 2024-08-16 |
| 79198 | SUPPL | 2024-07-24 |
| 79184 | SUPPL | 2024-07-24 |
| 77351 | SUPPL | 2024-01-29 |
| 77330 | SUPPL | 2024-01-29 |
| 72429 | ORIG | 2022-10-20 |
| 72139 | ORIG | 2022-09-22 |
| 72127 | ORIG | 2022-09-21 |
| 72126 | ORIG | 2022-09-21 |